Illumina(US:ILMN) ZACKS·2025-10-30 22:36分组1 - Illumina reported quarterly earnings of $1.34 per share, exceeding the Zacks Consensus Estimate of $1.16 per share, and showing an increase from $1.14 per share a year ago, resulting in an earnings surprise of +15.52% [1] - The company achieved revenues of $1.08 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.73%, with year-ago revenues also at $1.08 billion [2] - Illumina has surpassed consensus EPS estimates three times over the last four quarters and topped consensus revenue estimates four times during the same period [2] 分组2 - The stock has underperformed, losing about 28.9% since the beginning of the year, while the S&P 500 has gained 17.2% [3] - The current consensus EPS estimate for the coming quarter is $1.18 on revenues of $1.1 billion, and for the current fiscal year, it is $4.49 on revenues of $4.26 billion [7] - The Medical - Biomedical and Genetics industry, to which Illumina belongs, is currently in the top 38% of Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]